WallStreetZenWallStreetZen

NASDAQ: BBIO
Bridgebio Pharma Inc Stock Ownership - Who owns Bridgebio Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bridgebio Pharma Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Kkr Genetic Disorder LP10% Owner2024-09-135,800,000$25.75
$149.35MSell
Neil KumarChief Executive Officer2024-08-1911,197$25.13
$281.37kSell
Brian C. StephensonSecretary Treasurer CFO2024-08-192,457$24.39
$59.92kSell
Brian C. StephensonSecretary Treasurer CFO2024-08-191,698$25.13
$42.67kSell
Neil KumarChief Executive Officer2024-08-1916,192$24.39
$394.89kSell
Neil KumarChief Executive Officer2024-08-1628,148$24.40
$686.81kSell
Thomas TrimarchiPresident and COO2024-08-1617,936$24.40
$437.64kSell
Brian C. StephensonSecretary Treasurer CFO2024-08-1613,077$24.40
$319.08kSell
Randal W. ScottDirector2024-06-041,500$31.30
$46.95kSell
Randal W. ScottDirector2024-06-03200$29.48
$5.90kSell

1 of 4

BBIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BBIO insiders and whales buy or sell their stock.

BBIO Shareholders

What type of owners hold Bridgebio Pharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Kkr Group Partnership LP19.62%36,900,661$931.00MInsider
Kohlberg Kravis Roberts Co LP16.52%31,060,971$783.67MInstitution
Viking Global Performance LLC14.16%26,620,991$671.65MInsider
Kkr Genetic Disorder LP13.43%25,260,971$637.33MInsider
Viking Global Investors LP13.36%25,120,991$633.80MInsider
Viking Global Investors LP13.36%25,120,991$633.80MInstitution
Vanguard Group Inc7.47%14,054,748$354.60MInstitution
Blackrock Inc6.62%12,448,272$314.07MInstitution
Neil Kumar4.20%7,901,537$199.36MInsider
Aisling Capital Management LP3.23%6,068,125$153.10MInstitution

1 of 3

BBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BBIO58.08%41.92%Net SellingNet Selling
CORT31.73%68.27%Net BuyingNet Buying
MDGL25.45%74.55%Net BuyingNet Selling
ADMA76.44%23.56%Net SellingNet Selling
RNA87.27%12.73%Net SellingNet Selling
View Top Biotech Stocks

Bridgebio Pharma Stock Ownership FAQ

Who owns Bridgebio Pharma?

Bridgebio Pharma (NASDAQ: BBIO) is owned by 92.90% institutional shareholders, 67.05% Bridgebio Pharma insiders, and 0.00% retail investors. Kkr Group Partnership LP is the largest individual Bridgebio Pharma shareholder, owning 36.90M shares representing 19.62% of the company. Kkr Group Partnership LP's Bridgebio Pharma shares are currently valued at $916.61M.

If you're new to stock investing, here's how to buy Bridgebio Pharma stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.